Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio - 9-MTH group results

Feb 9 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Dec 31, 2022        Dec 31, 2021     Mar 31, 2023 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             60.21               45.66            78.70    
                 (+31.9 pct)         (+54.5 pct)      (+16.2 pct) 
  Operating         19.40               19.93            20.00    
                 (-2.6 pct)         (+126.7 pct)      (-30.8 pct) 
  Recurring         19.48               20.15            20.10    
                 (-3.3 pct)         (+126.0 pct)      (-29.4 pct) 
  Net               14.60               14.36            14.50    
                 (+1.6 pct)         (+150.8 pct)      (-27.0 pct) 
  EPS            121.21 yen          119.29 yen       120.42 yen  
  Ann Div                             33.00 yen        42.00 yen  
  -Q2 div            NIL                 NIL                      
  -Q4 div                             33.00 yen        42.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news